ATH434: Clinical Trials

1 trial of ATH434, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow ATH434: new trials by email Literature Review of ATH434 trials Research Report on ATH434

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Biomarker Study of ATH434 in Participants With MSA
ATH434 - Multiple System Atrophy
Phase 2CompletedAlterity Therapeutics102023-05-232025-04-01

Conditions studied

Movement Disorders (1)  ·  Multiple System Atrophy (1)  ·  Neurodegenerative Diseases (1)  ·  Primary Dysautonomias (1)  ·  Shy-Drager Syndrome (1)  ·  Synucleinopathies (1)

Sponsors

Alterity Therapeutics (1)

Countries

United States (1)